 The IAEA can now help more countries diagnose COVID-19 cases thanks to a pledge donation of around €4.3 million from Japanese biopharmaceutical company Takeda. So far, 119 countries have requested the IAEA's assistance to use a nuclear-based diagnostic technique as part of efforts to contain the virus. Several have already received equipment packages, with many more on the way. This latest pledge will allow the agency to ramp up efforts to deliver the kits. I thank Takeda for this important, generous contribution to the IAEA. Thanks to it, we will be able to continue our work, helping our member states combat and defeat coronavirus. The commitment from Takeda, one of the world's largest pharmaceutical firms, will add to the €22 million in funding that countries have already pledged for the IAEA's COVID-19 assistance programme. This is the nuclear agency's largest technical cooperation initiative since it was founded in 1957.